[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3003084T3 - Pharmaceutical compositions with micronised ebselen crystals - Google Patents

Pharmaceutical compositions with micronised ebselen crystals

Info

Publication number
GR3003084T3
GR3003084T3 GR91401696T GR910401696T GR3003084T3 GR 3003084 T3 GR3003084 T3 GR 3003084T3 GR 91401696 T GR91401696 T GR 91401696T GR 910401696 T GR910401696 T GR 910401696T GR 3003084 T3 GR3003084 T3 GR 3003084T3
Authority
GR
Greece
Prior art keywords
micronised
pharmaceutical compositions
ebselen
crystals
ebselen crystals
Prior art date
Application number
GR91401696T
Other languages
English (en)
Inventor
Axel Dr Roemer
Juergen Dr Seidel
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of GR3003084T3 publication Critical patent/GR3003084T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/10Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D293/12Selenazoles; Hydrogenated selenazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GR91401696T 1987-06-20 1991-11-07 Pharmaceutical compositions with micronised ebselen crystals GR3003084T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720493 DE3720493A1 (de) 1987-06-20 1987-06-20 Arzneizubereitungen mit mikronisierten ebselen-kristallen

Publications (1)

Publication Number Publication Date
GR3003084T3 true GR3003084T3 (en) 1993-02-17

Family

ID=6330016

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91401696T GR3003084T3 (en) 1987-06-20 1991-11-07 Pharmaceutical compositions with micronised ebselen crystals

Country Status (25)

Country Link
US (1) US5021242A (el)
EP (1) EP0296389B1 (el)
JP (1) JPH0713016B2 (el)
KR (1) KR970005322B1 (el)
AT (1) ATE69165T1 (el)
AU (1) AU603454B2 (el)
CA (1) CA1310906C (el)
DD (1) DD271056A5 (el)
DE (2) DE3720493A1 (el)
DK (1) DK173628B1 (el)
ES (1) ES2041736T3 (el)
FI (1) FI88256C (el)
GE (1) GEP19960342B (el)
GR (1) GR3003084T3 (el)
HU (1) HU200096B (el)
IE (1) IE63512B1 (el)
LT (1) LT3669B (el)
LV (1) LV10381B (el)
MX (1) MX169170B (el)
NO (1) NO175133C (el)
NZ (1) NZ225066A (el)
PT (1) PT87767B (el)
RU (1) RU1834657C (el)
UA (1) UA12648A (el)
ZA (1) ZA884025B (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368864A (en) * 1988-11-25 1994-11-29 Henning Berlin Gmbh Chemie- Und Pharmawerk Formulation of oxypurinol and/or its alkali and alkaline earth salts
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP2553434B2 (ja) * 1992-04-28 1996-11-13 第一製薬株式会社 粒状製剤
DE69328128T2 (de) * 1993-10-27 2000-08-24 Daiichi Pharmaceutical Co., Ltd. Granuläre zubereitung
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
ES2181868T3 (es) * 1995-02-28 2003-03-01 Aventis Pharma Inc Composicion farmaceutica para compuestos de piperidinoalcanol.
CZ295461B6 (cs) * 1997-08-26 2005-08-17 Aventis Pharmaceuticals Inc. Farmaceutický prostředek ve formě dvouvrstvé tablety
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
WO2000058281A1 (fr) 1999-03-31 2000-10-05 Daiichi Pharmaceutical Co., Ltd. Substrats pour thioredoxine reductase
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080293777A1 (en) * 2007-05-23 2008-11-27 Erlanson Daniel A Weight Loss Treatment
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
TW201613888A (en) 2014-09-26 2016-04-16 Helsinn Healthcare Sa Crystalline forms of an NK-1 antagonist
WO2022167778A1 (en) * 2021-02-02 2022-08-11 Haiku Therapeutics Ltd Ebselen as adenosine receptor modulator
WO2023240092A1 (en) * 2022-06-06 2023-12-14 Sound Pharmaceuticals Inc. Ebselen containing oral dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3027073C2 (de) * 1980-07-17 1985-03-07 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische Präparate, enthaltend 2-Phenyl-1,2-benzisoselenazol-3(2H)-on
DE3407511A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Benzisoselenazolthione, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3616923A1 (de) * 1986-05-20 1987-11-26 Nattermann A & Cie Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on
DE3620674A1 (de) * 1986-06-20 1987-12-23 Nattermann A & Cie Salbe zur behandlung von hauterkrankungen

Also Published As

Publication number Publication date
ZA884025B (en) 1988-12-20
HUT50037A (en) 1989-12-28
US5021242A (en) 1991-06-04
DE3720493A1 (de) 1989-01-26
HU200096B (en) 1990-04-28
DD271056A5 (de) 1989-08-23
NO882615D0 (no) 1988-06-14
FI882912A0 (fi) 1988-06-17
EP0296389A1 (de) 1988-12-28
EP0296389B1 (de) 1991-11-06
DK173628B1 (da) 2001-05-07
LT3669B (en) 1996-01-25
KR890000084A (ko) 1989-03-11
NO175133B (no) 1994-05-30
AU603454B2 (en) 1990-11-15
MX169170B (es) 1993-06-23
JPH01100125A (ja) 1989-04-18
DK333388A (da) 1988-12-21
ATE69165T1 (de) 1991-11-15
FI88256C (fi) 1993-04-26
KR970005322B1 (ko) 1997-04-15
IE881628L (en) 1988-12-20
PT87767B (pt) 1992-10-30
ES2041736T3 (es) 1996-07-16
DE3866033D1 (de) 1991-12-12
NO175133C (no) 1994-09-07
DK333388D0 (da) 1988-06-17
NO882615L (no) 1988-12-21
LTIP903A (en) 1995-03-27
GEP19960342B (en) 1996-02-20
CA1310906C (en) 1992-12-01
FI882912A (fi) 1988-12-21
IE63512B1 (en) 1995-05-03
NZ225066A (en) 1990-07-26
FI88256B (fi) 1993-01-15
LV10381A (lv) 1995-02-20
UA12648A (uk) 1997-02-28
PT87767A (pt) 1989-05-31
RU1834657C (ru) 1993-08-15
AU1811688A (en) 1988-12-22
JPH0713016B2 (ja) 1995-02-15
LV10381B (en) 1995-06-20

Similar Documents

Publication Publication Date Title
GR3003084T3 (en) Pharmaceutical compositions with micronised ebselen crystals
IL76454A (en) Diarylacetylene derivatives,their preparation and pharmaceutical compositions containing them
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
ZA867716B (en) Novel pharmacological compounds
IL60474A (en) Cyclopeptides of the somatostatin type,their manufacture and pharmaceutical compositions containing them
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
NZ185169A (en) 2,3-dihydroimidazo(2, 1-b) thiazole derivatives: process and pharmaceutical compositions
DE3566545D1 (en) 2-substituted-1,3-propylidenediphosphonate derivatives, the process for their preparation and pharmaceutical compositions containing them
IL76456A0 (en) 1-substituted tetralin derivatives,their preparation and pharmaceutical compositions containing them
IL52493A (en) 1,2-dihydro-5-benzoyl-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
DE2961394D1 (en) 1-oxo-1h-pyrimido (6,1-b) benzothiazole derivatives, processes for their preparation and pharmaceutical compositions containing them
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
EP0034276A3 (en) Phenylpiperazine derivatives of 1,3,4-oxadiazolyl phenols, their preparation and pharmaceutical compositions containing them
IL84331A0 (en) Pyridoxyl hydrazone derivatives and pharmaceutical compositions containing the same
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
DE3061614D1 (en) 2,3-dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them
IL85624A0 (en) Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL52492A (en) 5-furoyl-and 5-thenoyl-3h-pyrrolo(1,2-a)pyrrole-1-carboxylic acid derivatives,their production and pharmaceutical compositions containing them
PT84466A (en) Process for preparing aryl-azolylmethyl-benzocycloalkene derivatives and of pharmaceutical and fungicidal compositions containing the same
IL64827A0 (en) Fungicidal compositions containing certain amino acid derivatives and the preparation of these derivatives
AU6740187A (en) Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
AU549205B2 (en) Xipamide and triamterene composition
IL84129A (en) Bis(2,2-dialkylalkanoyl)-3-(4-trialkylbenzyl)-1-piperazinyl)-rifamycin s derivatives,their preparation and pharmaceutical compositions containing them